Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Technology

Set Alert for New Technology

PolarityTE Launches Two Trials Of SkinTE Chronic Wound Therapy

Patient enrollment has begun in trials of SkinTE human cellular and tissue skin-repair product for diabetic foot ulcers and venous leg ulcers, the Salt Lake City company announced April 1.

Clinical Trials Commercial Research & Development

Latest From Innovation

Pivotal Results Show MicroVention’s WEB Treats Challenging Brain Aneurysms

The Woven EndoBridge (WEB) aneurysm embolization system proved relatively safe and effective in the 150-patient WEB-IT trial. The trial results are now published in the Journal of Neurointerventional Surgery.

Clinical Trials Innovation

Medtronic's Endurant AAA And Valiant Navion SFA Featured At Charing Cross Symposium

Medtronic is encouraged by new data on endovascular repair of abdominal aortic aneurysm presented at the Charing Cross Symposium, including preliminary data from the ANCHOR registry on Endurant used in combination with the Heli-FX Endoanchor system. At the same meeting, 30-day results from 100 patients in the pivotal trial of Valiant Navion thoracic stent graft system showed high rates of procedural success in patients with a thoracic aortic aneurysm and penetrating atherosclerotic ulcer.

Clinical Trials Cardiovascular

Medtronic’s VenaSeal Proves Durable In Five-Year Results

Five-year outcomes from the VeClose Extension Study at the 2019 Charing Cross Symposium in London show the aggregate complete closure rate of the great saphenous vein was 94.6% in chronic venous disease patients treated with VenaSeal.

Clinical Trials Cardiovascular

Beyond The Hype: Philips CEO Says The Future Is AI Platforms

Philips CEO Frans von Houten says the future of health care is in AI platforms that will transform how effectively and efficiently patients are treated. He predicts the technology will be so ubiquitous that users will not even realize they are interacting with the technology.

Commercial Artificial Intelligence

Podcast: Philips CEO On Future Of AI, Health Care Systems

Philips CEO Frans von Houten sat down with Medtech Insight for an exclusive chat on the company’s philosophy for artificial intelligence and what is needed to fully embrace the technology as health care systems evolve.
Artificial Intelligence Business Strategies

QUOTED. April 19, 2019. Matt Likens.

GT Medical Technologies Inc. launched GammaTile permanent intracranial brachytherapy device, designed to be placed in the space left after the excision of a brain tumor. See what GT Medical Technologies' CEO and president Matt Likens said about it here.

Quoted Start-up Spotlight

Start-Up Spotlight: GT Medical Technologies' GammaTile Brings Brachytherapy Directly To Brain Tumors

Arizona-based GT Medical Technologies is ramping up commercialization of its GammaTile surgically targeted radiation therapy for patients with recurrent intracranial neoplasms. GammaTile already received 510(k) clearance, but continues to develop clinical evidence showing that GammaTile improves control of brain cancer following excision surgery and prolongs patient-survival.

Start-up Spotlight StartUps and SMEs

QUOTED. April 18, 2019. Cameron Piron.

At this year's annual American Association of Neurological Surgeons (AANS) conference, medical device makers demoed high-tech digital solutions for neurosurgeons. See what Synaptive Medical's president, Cameron Piron, said about its surgical planning software.

Quoted Neurology

Market Intel: #AANS2019: High-Tech Microscope Technologies Illuminate Brains, Spines

This year's annual American Association of Neurological Surgeons conference offered neurosurgeons and allied health professionals five days of clinical trial news, seminars and live-streaming videos to learn about the latest developments in their field. Medtech Insight had an ear close to the ground, posting Tweets on some of the latest technologies, including robotic-assisted microscopes, showcased by exhibiting companies. Here is a round-up of the best of the Tweets and updates from company executives.

Neurology Innovation
See All